Literature DB >> 15905550

Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice.

René Maehr1, Howard C Hang, Justine D Mintern, You-Me Kim, Armelle Cuvillier, Mikio Nishimura, Kenji Yamada, Kanae Shirahama-Noda, Ikuko Hara-Nishimura, Hidde L Ploegh.   

Abstract

Class II MHC molecules survey the endocytic compartments of APCs and present antigenic peptides to CD4 T cells. In this context, lysosomal proteases are essential not only for the generation of antigenic peptides but also for proteolysis of the invariant chain to allow the maturation of class II MHC molecules. Recent studies with protease inhibitors have implicated the asparagine endopeptidase (AEP) in class II MHC-restricted Ag presentation. We now report that AEP-deficient mice show no differences in processing of the invariant chain or maturation of class II MHC products compared with wild-type mice. In the absence of AEP, presentation to primary T cells of OVA and myelin oligodendrocyte glycoprotein, two Ags that contain asparagine residues within or in proximity to the relevant epitopes was unimpaired. Cathepsin (Cat) L, a lysosomal cysteine protease essential for the development to CD4 and NK T cells, fails to be processed into its mature two-chain form in AEP-deficient cells. Despite this, the numbers of CD4 and NK T cells are normal, showing that the single-chain form of Cat L is sufficient for its function in vivo. We conclude that AEP is essential for processing of Cat L but not for class II MHC-restricted Ag presentation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15905550     DOI: 10.4049/jimmunol.174.11.7066

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

Review 1.  Endolysosomal proteases and their inhibitors in immunity.

Authors:  Phillip I Bird; Joseph A Trapani; José A Villadangos
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

Review 2.  Proteolysis mediated by cysteine cathepsins and legumain-recent advances and cell biological challenges.

Authors:  Klaudia Brix; Joseph McInnes; Alaa Al-Hashimi; Maren Rehders; Tripti Tamhane; Mads H Haugen
Journal:  Protoplasma       Date:  2014-11-16       Impact factor: 3.356

3.  BDNF inhibits neurodegenerative disease-associated asparaginyl endopeptidase activity via phosphorylation by AKT.

Authors:  Zhi-Hao Wang; Wanqiang Wu; Seong Su Kang; Xia Liu; Zhiping Wu; Junmin Peng; Shan Ping Yu; Fredric P Manfredsson; Ivette M Sandoval; Xuebo Liu; Jian-Zhi Wang; Keqiang Ye
Journal:  JCI Insight       Date:  2018-08-23

4.  Synthesis and evaluation of aza-peptidyl inhibitors of the lysosomal asparaginyl endopeptidase, legumain.

Authors:  Jiyoun Lee; Matthew Bogyo
Journal:  Bioorg Med Chem Lett       Date:  2011-12-21       Impact factor: 2.823

5.  Negative self-regulation of TLR9 signaling by its N-terminal proteolytic cleavage product.

Authors:  Sungwook Lee; Dongju Kang; Eun A Ra; Taeyun A Lee; Hidde L Ploegh; Boyoun Park
Journal:  J Immunol       Date:  2014-09-03       Impact factor: 5.422

6.  Design of cell-permeable, fluorescent activity-based probes for the lysosomal cysteine protease asparaginyl endopeptidase (AEP)/legumain.

Authors:  Kelly B Sexton; Martin D Witte; Galia Blum; Matthew Bogyo
Journal:  Bioorg Med Chem Lett       Date:  2006-11-06       Impact factor: 2.823

7.  The asparaginyl endopeptidase legumain after experimental stroke.

Authors:  Taku Ishizaki; Agnes Erickson; Enida Kuric; Mehrdad Shamloo; Ikuko Hara-Nishimura; Ana Rita Lourenço Inácio; Tadeusz Wieloch; Karsten Ruscher
Journal:  J Cereb Blood Flow Metab       Date:  2010-03-17       Impact factor: 6.200

8.  Development of near-infrared fluorophore (NIRF)-labeled activity-based probes for in vivo imaging of legumain.

Authors:  Jiyoun Lee; Matthew Bogyo
Journal:  ACS Chem Biol       Date:  2010-02-19       Impact factor: 5.100

9.  Functional imaging of legumain in cancer using a new quenched activity-based probe.

Authors:  Laura E Edgington; Martijn Verdoes; Alberto Ortega; Nimali P Withana; Jiyoun Lee; Salahuddin Syed; Michael H Bachmann; Galia Blum; Matthew Bogyo
Journal:  J Am Chem Soc       Date:  2012-12-18       Impact factor: 15.419

10.  Cystatin E/M suppresses legumain activity and invasion of human melanoma.

Authors:  Jon J Briggs; Mads H Haugen; Harald T Johansen; Adam I Riker; Magnus Abrahamson; Øystein Fodstad; Gunhild M Maelandsmo; Rigmor Solberg
Journal:  BMC Cancer       Date:  2010-01-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.